IncFact
Company Profiles: Revenue, Growth, Competition

Endo Pharmaceuticals Revenue, Growth & Competitor Profile

DBA ENDO HEALTH SOLUTION INC.
DBA ENDO HEALTH SOLUTIONS INC.
DBA ENDO PHARMACEUTICALS HOLDINGS INC
Last updated:

Company Awards

Big Fish
Big Fish
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Endo Pharmaceuticals

Access the complete profile.

Endo Pharmaceuticals Fast Facts

Revenue$100 - $500 million    See Exact Annual Revenue
EmployeesOver 1,000Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Additional NAICS Codes325412 Pharmaceutical Preparation Manufacturing
Address1400 Atwater Drive
Malvern, PA 19355

Note: Revenues for privately held companies are statistical evaluations.


Endo Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?
    • Endo Pharmaceuticals is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Endo Pharmaceuticals Annual Revenue and Growth Rate

Endo Pharmaceuticals Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 $100 - $500 million

Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Endo Pharmaceuticals's revenues are gauged from an analysis of company filings.



Endo Pharmaceuticals's Income Statement (based on Industry Averages)

Endo Pharmaceuticals P&L$ Millions
Revenue (Sales) Endo Pharmaceuticals Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Endo Pharmaceuticals is developing and marketing. Endo Pharmaceuticals doesn't have any recent trademark applications, indicating Endo Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
ENDO GENERICS PAR PHARMACEUTICAL
Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations and medicines, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies
03/15/2022
ENDO INJECTABLE SOLUTIONS
Educational services, namely, conducting classes, seminars, and workshops in the field of pharmaceutical preparations and medicines, medical devices and techniques; Educational services, namely, conducting classes, seminars, workshops and training for doctors, nurses and others in the fields of critical care, critical testing, maternal health, rare diseases and conditions, anesthesia, and aesthetic solutions to help patients feel better about their bodies
01/14/2022
E.P.I.C. ELEVATING PRACTICES. INSPIRING CONSUMERS.
Administering purchasing programs by tracking purchase volume of aesthetic medical product to provide reimbursement for advertising expenses for participant members in the medical field; promoting the sale of esthetic medical products through the administration of an incentive award program to participant members in the medical field
08/10/2021

See all trademarks and details in the Full Report.


Market Share of Endo Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Endo Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSDenver, CO100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM30 
INC RESEARCHRaleigh, NC27 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
SYNEOS HEALTHRaleigh, NC13 
ILLUMINASan Diego, CA12 
UT-BATTELLEOak Ridge, TN11 
PRA HOLDINGSRaleigh, NC11 




Nearby Competitors

These companies are similar in business line and location to Endo Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
ENDO PHARMACEUTICALSMalvern, PA100 
FRONTAGE LABORATORIESExton, PA73 
NEURONETICSMalvern, PA21 
REACTION BIOLOGYMalvern, PA16 
ALLIANCE PHARMAMalvern, PA14 
OCUGENMalvern, PA10 




Future Competition: Endo Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Endo Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Endo Pharmaceuticals Competitors